No black box warning on record for Inlyta

As of the latest FDA labeling reviewed, Inlyta (AXITINIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Inlyta medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypertension: Hypertension including hypertensive crisis has been observed. Blood pressure should be well-controlled prior to initiating INLYTA. Monitor for hypertension and treat as needed. Withhold and then dose reduce INLYTA or permanently discontinue based on severity of hypertension. ( 5.1 ) • Arterial and Venous Thromboembolic Events: Arterial and venous thrombot

No black box warning on record for Inlyta

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypertension: Hypertension including hypertensive crisis has been observed. Blood pressure should be well-controlled prior to initiating INLYTA. Monitor for hypertension and treat as needed. Withhold and then dose reduce INLYTA or permanently discontinue based on severity of hypertension. ( 5.1 ) • Arterial and Venous Thromboembolic Events: Arterial and venous thrombot

Inlyta Black Box Warning

No black box warning on record for Inlyta

Other warnings & precautions

Inlyta Black Box Warning

No black box warning on record for Inlyta

Other warnings & precautions